Contact us

News Center

Filters
Filters
Category
Search
Show (34)
Cancel
image (20)
Business

Bora Pharmaceuticals Makes a Strategic Investment into Tanvex to Provide Global BioManufacturing Services.

  Taipei, Taiwan, August 27, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that

Bora-Emergent Closing
Business

Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent

TAIPEI, TAIWAN, August 20th 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a a global leader

Bobby Sheng and President Tsai Ing-wen
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Taiwan, 8th December 2023: As being the largest pharmaceutical company in Taiwan, we are proud to announce that Bora Pharmaceuticals was honored

2024 Best companies to work for
Business

Bora Recognized with Dual Accolades at Asia Best Companies to Work for Awards 2024

《HR Asia》, the leading HR magazine in Asia, recently announced the winners of the 2024 "The HR Asia Best Companies
Emergent Bora announcement
Business

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Bora Pharmaceuticals announced it entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of
Presidential Innovation Award
Business

Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake

The Office of the President Taiwan announced the winners of the 6th “Presidential Innovation” Award, and Bora Pharmaceuticals has been
Bora-USL3
Business

Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith

Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, USA.
SunWay and Gnosis by Lesaffre Form Alliance
Business

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

SunWay Biotech and Gnosis by Lesaffre has announced a strategic partnership to launch their inaugural product, MenaQ7® Metabolic, featuring the
Upsher-Smith
Business

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the
2024 JPM Healthcare Conference
Events, Investors

42nd Annual J.P. Morgan Healthcare Conference

Bora Pharmaceuticals has been invited to participate in the prestigious J.P. Morgan Healthcare Conference and will be hosting a company

Bora

Contact

Address

  • 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan
Youtube Linkedin

Quick Links

Copyright © 2025 Bora Pharmaceuticals. Developed by Engage.